Hemostasis Diagnostics Market

Hemostasis Diagnostics Market is valued around USD 2228.8 Million in 2018 and expected to reach USD 3948.6 Million by 2025 with the CAGR of 8.1% over the forecast period.

Increased prevalence of blood clotting disorders and increase in technological advancements are the key drivers for Global Hemostasis Diagnostics Market.

Market Analysis of Hemostasis Diagnostics -

Hemostasis Diagnostics market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about hemostasis diagnostics market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of hemostasis diagnostics market. This report consists of regional segmentation with product type, test type, and end use.

Hemostasis diagnostic are those devices which help in the identification of hemostatic defects which leads to excessive bleeding. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis is a mechanism followed by the body after getting injured, it slows down the blood loss and stop the blood flow. This process is followed by three steps which include vasoconstriction, platelet plug formation and blood coagulation. Hemostasis helps in the diagnosis of actual cause of these disorders with history and helps in the treatment.

Hemostasis diagnostics market report is segmented based on product type, test type, end users and by regional & country level. Based upon product type, hemostasis diagnostics market is classified into laboratory systems, consumables, point-of-care testing systems. Based upon test type, hemostasis diagnostics market is classified into prothrombin time, activated partial thromboplastin time, fibrinogen degradation products, activated clotting time, platelet aggregation test and D dimer. Based upon end users, hemostasis diagnostics market is classified into hospital/clinics, independent diagnostic, laboratories and other.

The regions covered in this hemostasis diagnostics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of hemostasis diagnostics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Hemostasis Diagnostics Companies

Hemostasis diagnostics market report covers prominent players like,

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Nihon Kohden Corporation
• Thermo fisher Scientific Inc.
• Danaher Corporation
• Sysmex Corporation
• Siemens Healthineers
• Instrumentation Laboratory
• Grifols S.A
• HORIBA Europe Holding
• Medtronic
• Technidyne Corporation
• BD
• Haemonetics Corporation
• Beckman Coulter Inc.
• Labmedics 

Hemostasis Diagnostics Market are those devices which help in the identification of hemostatic defects which leads to excessive bleeding. Hemostasis is a mechanism followed by the body after getting injured, it slows down the blood loss and stop the blood flow. This process is followed by three steps which include vasoconstriction, platelet plug formation and blood coagulation. Hemostasis helps in the diagnosis of actual cause of these disorders with history and helps in the treatment.

Hemostasis Diagnostics Market Segmentation –

By Product Type:

• Laboratory Systems
• Consumables
• Point-of-Care Testing Systems

By Test Type:

• Prothrombin Time
• Activated Partial Thromboplastin Time
• Fibrinogen Degradation Products
• Activated Clotting Time
• Platelet Aggregation Test
• D Dimer

By End User:

• Hospital/Clinics
• Independent Diagnostic
• Laboratories
• Other

Regional & Country Analysis

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Haemonetics acquires blood coagulation testing system developer Enicor

News: April 3, 2020, Hemonetics announced that it acquired next-generation whole blood coagulation testing system developer Enicor for an undisclosed amount. Munich, Germany-based Enicor develops the ClotPro system designed for viscoelastic diagnostics touted to offer more assays than any other hemostasis analyzer on the market. As per the Haemonetics, ClotPro is set to be coupled with its TEG 5000 hemostasis analyzer and TEG 6s hemostasis analyzer with site-of-care technology.

Hemostasis Diagnostics Market Dynamics –

Rising prevalence of disease driving the growth of market. As per the report by the World Health Organization, around 400, 000 people worldwide suffer from hemophilia, of which 56% remain undiagnosed. This will flourish the growth of the hemostasis diagnostics market. Additionally, technological advancement leading to the development of novel advanced products for hemostasis. This helps healthcare professionals to perform varied tasks and bring about efficiency and efficacy in hemostasis diagnostics. On the other flip less awareness about disease in certain region may restrain the growth of market. Nevertheless, increasing government initiative are expected to create lucrative opportunity in the market.

Hemostasis Diagnostics Market Regional Analysis –

North America dominates the market and expected to share highest market over the forecast period. The dominance of this region is due to the increased healthcare infrastructure, and the presence of large patient pool and high adoption of advanced automated analyzers. In addition, high spending on healthcare helps to dominate the region, for instance, U.S. health care spending grew 4.6 percent in 2018, reaching around USD 3.6 trillion or USD 11,172 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 17.7 percent.

The Asia-Pacific is expected to witness the fastest growth over the forecast period owing to currently undergoing a paradigm shift and are investing huge amount of government funds to procure and install such medical devices into their public healthcare facilities. Additionally, increasing awareness and presence of a huge patient pool in developing economies such as India and China can further fuel the regional demand.